E. Mccleskey and M. Gold, ION CHANNELS OF NOCICEPTION, Annual Review of Physiology, vol.61, issue.1, pp.835-56, 1999.
DOI : 10.1146/annurev.physiol.61.1.835

A. Meir, S. Ginsburg, and A. Butkevich, Ion channels in presynaptic nerve terminals and control of transmitter release, Physiol Rev, vol.79, pp.1019-88, 1999.

E. Ertel, K. Campbell, and M. Harpold, Nomenclature of Voltage-Gated Calcium Channels, Neuron, vol.25, issue.3, pp.533-538, 2000.
DOI : 10.1016/S0896-6273(00)81057-0

S. Hatakeyama, M. Wakamori, and M. Ino, Differential nociceptive responses in mice lacking the ??1B subunit of N-type Ca2+ channels, Neuroreport, vol.12, issue.11, pp.2423-2430, 2001.
DOI : 10.1097/00001756-200108080-00027

H. Saegusa, T. Kurihara, and S. Zong, Suppression of inflammatory and neuropathic pain symptoms in mice lacking the N-type Ca2+ channel, The EMBO Journal, vol.20, issue.10, pp.2349-56, 2001.
DOI : 10.1093/emboj/20.10.2349

L. Kerr and D. Yoshikami, A venom peptide with a novel presynaptic blocking action, Nature, vol.9, issue.5956, pp.282-286, 1984.
DOI : 10.1038/308282a0

B. Olivera, L. Cruz, and V. De-santos, Neuronal calcium channel antagonists. Discrimination between calcium channel subtypes using .omega.-conotoxin from Conus magus venom, Biochemistry, vol.26, issue.8, pp.2086-90, 1987.
DOI : 10.1021/bi00382a004

A. Malmberg and T. Yaksh, Effect of continuous intrathecal infusion of ??-conopeptides, N-type calcium-channel blockers, on behavior and antinociception in the formalin and hot-plate tests in rats, Pain, vol.60, issue.1, pp.83-90, 1995.
DOI : 10.1016/0304-3959(94)00094-U

S. Chaplan, J. Pogrel, and T. Yaksh, Role of voltage-dependent calcium channel subtypes in experimental tactile allodynia, J Pharmacol Exp Ther, vol.269, pp.1117-1140, 1994.

P. Staats, T. Yearwood, and S. Charapata, Intrathecal Ziconotide in the Treatment of Refractory Pain in Patients With Cancer or AIDS, JAMA, vol.291, issue.1, pp.63-70, 2004.
DOI : 10.1001/jama.291.1.63

R. Penn and J. Paice, Adverse effects associated with the intrathecal administration of ziconotide, Pain, vol.85, issue.1, pp.291-297, 2000.
DOI : 10.1016/S0304-3959(99)00254-7

D. Adams, A. Smith, and C. Schroeder, omega -Conotoxin CVID Inhibits a Pharmacologically Distinct Voltage-sensitive Calcium Channel Associated with Transmitter Release from Preganglionic Nerve Terminals, Journal of Biological Chemistry, vol.278, issue.6, pp.4057-62, 2003.
DOI : 10.1074/jbc.M209969200

M. Smith, P. Cabot, and F. Ross, The novel N-type calcium channel blocker, AM336, produces potent dose-dependent antinociception after intrathecal dosing in rats and inhibits substance P release in rat spinal cord slices, Pain, vol.96, issue.1, pp.119-146, 2002.
DOI : 10.1016/S0304-3959(01)00436-5

D. Blake, D. Scott, J. Angus, and C. Wright, Synergy between intrathecal ??-conotoxin CVID and dexmedetomidine to attenuate mechanical hypersensitivity in the rat, European Journal of Pharmacology, vol.506, issue.3, pp.221-228, 2005.
DOI : 10.1016/j.ejphar.2004.11.016

T. Seko, M. Kato, and H. Kohno, Structure???Activity Study of l-Cysteine-Based N-Type Calcium Channel Blockers: Optimization of N- and C-Terminal Substituents, Bioorganic & Medicinal Chemistry Letters, vol.12, issue.6, pp.915-923, 2002.
DOI : 10.1016/S0960-894X(02)00032-X

E. Teodori, E. Baldi, and S. Dei, Design, Synthesis, and Preliminary Pharmacological Evaluation of 4-Aminopiperidine Derivatives as N-Type Calcium Channel Blockers Active on Pain and Neuropathic Pain, Journal of Medicinal Chemistry, vol.47, issue.24, pp.6070-81, 2004.
DOI : 10.1021/jm049923l

T. Bell, C. Thaler, and A. Castiglioni, Cell-Specific Alternative Splicing Increases Calcium Channel Current Density in the Pain Pathway, Neuron, vol.41, issue.1, pp.127-165, 2004.
DOI : 10.1016/S0896-6273(03)00801-8

E. Seward, C. Hammond, and G. Henderson, Formula-Opioid-receptor-mediated Inhibition of the N-Type Calcium-Channel Current, Proceedings of the Royal Society B: Biological Sciences, vol.244, issue.1310, pp.129-164, 1991.
DOI : 10.1098/rspb.1991.0061

D. Waard, M. Liu, H. Walker, and D. , Direct binding of G-protein ???? complex to voltage-dependent calcium channels, Nature, vol.385, issue.6615, pp.446-50, 1997.
DOI : 10.1038/385446a0

G. Zamponi, E. Bourinet, and D. Nelson, Crosstalk between G proteins and protein kinase C mediated by the calcium channel ??1 subunit, Nature, vol.385, issue.6615, pp.442-448, 1997.
DOI : 10.1038/385442a0

C. Marker, R. Lujan, H. Loh, and K. Wickman, Spinal G-Protein-Gated Potassium Channels Contribute in a Dose-Dependent Manner to the Analgesic Effect of ??- and ??- But Not ??-Opioids, Journal of Neuroscience, vol.25, issue.14, pp.3551-3560, 2005.
DOI : 10.1523/JNEUROSCI.4899-04.2005

A. Wise, K. Gearing, and S. Rees, Target validation of G-protein coupled receptors, Drug Discovery Today, vol.7, issue.4, pp.235-281, 2002.
DOI : 10.1016/S1359-6446(01)02131-6

J. Meunier, Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor, European Journal of Pharmacology, vol.340, issue.1, pp.1-15, 1997.
DOI : 10.1016/S0014-2999(97)01411-8

A. Beedle, J. Mcrory, and O. Poirot, Agonist-independent modulation of N-type calcium channels by ORL1 receptors, Nature Neuroscience, vol.7, issue.2, pp.118-143, 2004.
DOI : 10.1038/nn1180

R. Ophoff, G. Terwindt, and M. Vergouwe, Familial Hemiplegic Migraine and Episodic Ataxia Type-2 Are Caused by Mutations in the Ca2+ Channel Gene CACNL1A4, Cell, vol.87, issue.3, pp.543-52, 1996.
DOI : 10.1016/S0092-8674(00)81373-2

D. Pietrobon and J. Striessnig, Neurological diseases: Neurobiology of migraine, Nature Reviews Neuroscience, vol.4, issue.5, pp.386-98, 2003.
DOI : 10.1038/nrn1102

K. Yokoyama, T. Kurihara, and H. Saegusa, Blocking the R-type (Cav2.3) Ca2+ channel enhanced morphine analgesia and reduced morphine tolerance, European Journal of Neuroscience, vol.77, issue.12, pp.3516-3525, 2004.
DOI : 10.1016/S0896-6273(00)80836-3

H. Saegusa, T. Kurihara, and S. Zong, Altered pain responses in mice lacking alpha 1E subunit of the voltage-dependent Ca2+ channel, Proceedings of the National Academy of Sciences, vol.97, issue.11, pp.6132-6139, 2000.
DOI : 10.1073/pnas.100124197

S. Todorovic, S. Pathirathna, A. Meyenburg, and V. Jevtovic-todorovic, Mechanical and thermal anti-nociception in rats after systemic administration of verapamil, Neuroscience Letters, vol.360, issue.1-2, pp.57-60, 2004.
DOI : 10.1016/j.neulet.2004.02.049

M. Murakami, B. Fleischmann, D. Felipe, and C. , Pain Perception in Mice Lacking the ??3 Subunit of Voltage-activated Calcium Channels, Journal of Biological Chemistry, vol.277, issue.43, pp.40342-51, 2002.
DOI : 10.1074/jbc.M203425200

D. Bichet, V. Cornet, and S. Geib, The I-II Loop of the Ca2+ Channel ??1 Subunit Contains an Endoplasmic Reticulum Retention Signal Antagonized by the ?? Subunit, Neuron, vol.25, issue.1, pp.177-90, 2000.
DOI : 10.1016/S0896-6273(00)80881-8

I. Cuchillo-ibanez, M. Aldea, and J. Brocard, Inhibition of voltage-gated calcium channels by sequestration of ?? subunits, Biochemical and Biophysical Research Communications, vol.311, issue.4, pp.1000-1007, 2003.
DOI : 10.1016/j.bbrc.2003.10.102

R. Newton, S. Bingham, and P. Case, Dorsal root ganglion neurons show increased expression of the calcium channel ??2??-1 subunit following partial sciatic nerve injury, Molecular Brain Research, vol.95, issue.1-2, pp.1-8, 2001.
DOI : 10.1016/S0169-328X(01)00188-7

Z. Luo, S. Chaplan, and E. Higuera, Upregulation of dorsal root ganglion (alpha)2(delta) calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats, J Neurosci, vol.21, pp.1868-75, 2001.

C. Li, Y. Song, E. Higuera, and Z. Luo, Spinal Dorsal Horn Calcium Channel ??2??-1 Subunit Upregulation Contributes to Peripheral Nerve Injury-Induced Tactile Allodynia, Journal of Neuroscience, vol.24, issue.39, pp.8494-8503, 2004.
DOI : 10.1523/JNEUROSCI.2982-04.2004

S. Todorovic, A. Meyenburg, and V. Jevtovic-todorovic, Mechanical and thermal antinociception in rats following systemic administration of mibefradil, a T-type calcium channel blocker, Brain Research, vol.951, issue.2, pp.336-376, 2002.
DOI : 10.1016/S0006-8993(02)03350-4

A. Dogrul, L. Gardell, and M. Ossipov, Reversal of experimental neuropathic pain by T-type calcium channel blockers, Pain, vol.105, issue.1, pp.159-68, 2003.
DOI : 10.1016/S0304-3959(03)00177-5

S. Flatters and G. Bennett, Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy, Pain, vol.109, issue.1, pp.150-61, 2004.
DOI : 10.1016/j.pain.2004.01.029

S. Todorovic, S. Pathirathna, and B. Brimelow, 5??-Reduced Neuroactive Steroids Are Novel Voltage-Dependent Blockers of T-Type Ca2+ Channels in Rat Sensory Neurons in Vitro and Potent Peripheral Analgesics in Vivo, Molecular Pharmacology, vol.66, issue.5, pp.1223-1258, 2004.
DOI : 10.1124/mol.104.002402

S. Todorovic, A. Meyenburg, and V. Jevtovic-todorovic, Redox modulation of peripheral T-type Ca2+ channels in vivo: alteration of nerve injury-induced thermal hyperalgesia, Pain, vol.109, issue.3, pp.328-367, 2004.
DOI : 10.1016/j.pain.2004.01.026

E. Bourinet, A. Alloui, and A. Monteil, Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception, The EMBO Journal, vol.16, issue.2, pp.315-339, 2005.
DOI : 10.1038/sj.emboj.7600515
URL : https://hal.archives-ouvertes.fr/hal-00016908

M. Burian and G. Geisslinger, COX-dependent mechanisms involved in the antinociceptive action of NSAIDs at central and peripheral sites, Pharmacology & Therapeutics, vol.107, issue.2, pp.139-54, 2005.
DOI : 10.1016/j.pharmthera.2005.02.004

F. Coluzzi and C. Mattia, Mechanism-Based Treatment in Chronic Neuropathic Pain: The Role of Antidepressants, Current Pharmaceutical Design, vol.11, issue.23, pp.2945-60, 2005.
DOI : 10.2174/1381612054864993

R. Eglen, J. Hunter, and A. Dray, Ions in the fire: recent ion-channel research and approaches to pain therapy, Trends in Pharmacological Sciences, vol.20, issue.8, pp.337-379, 1999.
DOI : 10.1016/S0165-6147(99)01372-3

M. Jarvis, E. Burgard, and S. Mcgaraughty, A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat, Proceedings of the National Academy of Sciences, vol.99, issue.26, pp.17179-84, 2002.
DOI : 10.1073/pnas.252537299

L. Vyklicky, H. Knotkova-urbancova, and Z. Vitaskova, Inflammatory mediators at acidic pH activate capsaicin receptors in cultured sensory neurons from newborn rats, J Neurophysiol, vol.79, pp.670-676, 1998.

N. Voilley, Acid-Sensing Ion Channels (ASICs): New Targets for the Analgesic Effects of Non-Steroid Anti-Inflammatory Drugs (NSAIDs), Current Drug Target -Inflammation & Allergy, vol.3, issue.1, pp.71-80, 2004.
DOI : 10.2174/1568010043483980
URL : https://hal.archives-ouvertes.fr/hal-00091455

J. Wilson, E. Garry, and H. Anderson, NMDA receptor antagonist treatment at the time of nerve injury prevents injury-induced changes in spinal NR1 and NR2B subunit expression and increases the sensitivity of residual pain behaviours to subsequently administered NMDA receptor antagonists, Pain, vol.117, issue.3, pp.421-453, 2005.
DOI : 10.1016/j.pain.2005.07.005

D. Lossignol, M. Obiols-portis, and J. Body, Successful use of ketamine for intractable cancer pain, Supportive Care in Cancer, vol.63, issue.3, pp.188-93, 2005.
DOI : 10.1007/s00520-004-0684-4